Healthcare Services

Global Disease Registry Software Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Disease Registry Software Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The disease registry software market has experienced significant expansion in recent years. This market is set to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Contributing factors to this historical growth include the escalating digitization of patient records, the enlargement of disease-specific research programs, heightened regulatory reporting requirements, the widespread adoption of electronic health records, and the increasing reliance on data-driven clinical decision tools.

The disease registry software market is projected for substantial expansion in the coming years. This market is set to reach $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth is driven by factors such as a heightened need for population health analytics, increased integration with AI-powered clinical insights, wider deployment of cloud-based registries, an intensified emphasis on outcomes-based healthcare, and greater utilization of real-world data in clinical studies. Key trends for this period encompass the growing adoption of integrated disease registry platforms, increased reliance on cloud-based patient data management, a heightened focus on regulatory-compliant data reporting, the broadening of EHR-integrated registry solutions, and a stronger emphasis on gathering real-world evidence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

What Drivers Are Influencing The Disease Registry Software Market?

The growing embrace of personalized medicine is projected to stimulate the expansion of the disease registry software market in the future. Personalized medicine defines a medical methodology that customizes treatment and prevention strategies based on an individual’s distinct genetic composition, way of life, and environment. This rise in personalized medicine adoption is primarily attributed to breakthroughs in genomics, which facilitate accurate identification of genetic variations and personalized therapeutic interventions. Disease registry software plays a crucial role in supporting personalized medicine by systematically gathering and organizing patient health information, thereby enabling customized treatment approaches and better clinical choices. It also simplifies access to and analysis of data, which improves patient results and advances precision healthcare. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, which is a considerable jump from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is accelerating the growth of the disease registry software market.

What Major Segment Divisions Exist Within The Disease Registry Software Market?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Which Trends Are Shaping The Future Of The Disease Registry Software Market?

Leading firms within the disease registry software sector are prioritizing the creation of patient-focused registries, including digital solutions, to monitor outcomes and facilitate tailored care. These digital registers represent electronic systems or software platforms designed for the systematic collection, storage, and management of patient health data, thereby substituting conventional paper-based records. An example is the launch of the CONNECT-HCM Registry by the American College of Cardiology (ACC), a US-based nonprofit medical association, in August 2025. This nationwide digital registry aims to enhance comprehension and treatment of hypertrophic cardiomyopathy (HCM), which is the most prevalent genetic cardiovascular condition. It allows patients to enroll directly from various locations, not just individual centers, thereby filling persistent gaps in diagnosis and care. The platform integrates its registry information with electronic health records through Arboretum’s Hugo Connect platform, assisting researchers in monitoring symptoms, imaging results, treatments, and patient outcomes across an extended period.

Which Companies Are Leading Innovation In The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Read the full disease registry software market report here:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Disease Registry Software Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28208&type=smp

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Disease Management Apps Global Market Report

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Global Market Report

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Healthcare Compliance Software Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795